Rheumatoid Arthritis (RA) Medications
William C. Shiel Jr., MD, FACP, FACR
Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.
Catherine Burt Driver, MD
Catherine Burt Driver, MD, is board certified in internal medicine and rheumatology by the American Board of Internal Medicine. Dr. Driver is a member of the American College of Rheumatology. She currently is in active practice in the field of rheumatology in Mission Viejo, Calif., where she is a partner in Mission Internal Medical Group.
- What are the different types of rheumatoid arthritis medicines?
- What are common side effects of rheumatoid arthritis medications?
- Where can people find more information about side effects of prescription rheumatoid arthritis drugs?
What are the different types of rheumatoid arthritis medicines?
Rheumatoid arthritis responds most effectively to treatment when it is initiated early. It is then easier to treat and easier to respond to treatments. Medications used to treat rheumatoid arthritis range from nonsteroidal anti-inflammatory drugs (NSAIDs such as Mobic [meloxicam], Voltaren [diclofenac], and Celebrex [celecoxib]) and cortisone drugs (such as Deltasone [prednisone]) to disease-modifying antirheumatic drugs (DMARDs), including antimalarials (such as Plaquenil [hydroxychloroquine]), Rheumatrex, Trexall (methotrexate), Azulfidine (sulfasalazine), Imuran (azathioprine), Arava (leflunomide), and Sandimmune (cyclosporine).
Newer biologic treatments include Enbrel (etanercept), Remicade (infliximab), Humira (adalimumab), Rituxan (rituximab), Simponi (golimumab), Cimzia (certolizumab), Orencia (abatacept), Actemra (tocilizumab), and Xeljanz (tofacitinib).
Get the latest treatment options